LLY
48
-2
TDC
59
10
NSC
62
-5
MDT
53
-2
MCHP
43
-6
ADM
33
-3
MU
34
3
LYB
46
-4
ITW
62
-2
RCL
76
2
TRIP
66
5
SWN
77
4
GPC
37
-14
PCG
80
3
NTRS
49
-5
GME
63
12
URI
58
-5
ILMN
41
-3
ADI
59
-2
NVDA
52
-3
LLY
48
-2
TDC
59
10
NSC
62
-5
MDT
53
-2
MCHP
43
-6
ADM
33
-3
MU
34
3
LYB
46
-4
ITW
62
-2
RCL
76
2
TRIP
66
5
SWN
77
4
GPC
37
-14
PCG
80
3
NTRS
49
-5
GME
63
12
URI
58
-5
ILMN
41
-3
ADI
59
-2
NVDA
52
-3
Financhill
Back

Riot Platforms Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
31

RIOT
Riot Platforms

Last Price:
7.19
Seasonality Move:
34.34%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
31
Riot Platforms (RIOT) is a Sell

Is Riot Platforms a Buy, Sell or Hold?

  • The current Riot Platforms [RIOT] share price is $7.19. The Score for RIOT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • RIOT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RIOT Stock Price Chart

What is Riot Platforms's stock price today?

  • The Riot Platforms share price today is $7.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RIOT is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

RIOT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 43.91 Sell
Chaikin Money Flow: 13357745 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.85 - 8.01) Sell
Bollinger Bands (100): (7.85 - 10.77) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

RIOT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.12 Buy
20-day SMA: 7.27 Sell
50-day SMA: 8.66 Sell
200-day SMA: 11.14 Sell
8-day EMA: 7.14 Buy
20-day EMA: 7.35 Sell
50-day EMA: 8.18 Sell
200-day EMA: 10.08 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Riot Platforms Earnings Growth & RIOT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.10 per share, an increase this year of $1.45 per share, and a decrease next year of $0.07 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Riot Platforms Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):